AI
Friday, April 12, 2019 3:09:56 PM
I think that's considered marketing their CBD products. They have two lines of CBD products that they are using for topical lotions. I believe marketing their availability and uses as an alternative to opioids is considered good business practice to increase revenues and profits for all businesses in the retail field, not just pharmacy retail. Just saying. Lol. Seems pretty clear to me.
And for a company that this posts states is failing, they seem to be doing very well to me over the past several years. I will let the numbers speak for RXMD, not baseless opinions. Stock price going from $.005 to now over $.06 and as high as $.2659 kinda coincides with that growth and achievements, not failures.
OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS
RXMD Revenues per location, Second to None
Penny Stock Exempt with low Share Structure
RXMD Compared to the Competition WOWSERS!!!
RXMD Retail Stores Commence Major Expansion Across Florida
RXMD 5 Star Humana Rating Earns Them Highest Payout
3 YEARS AUDITED F/S
Big Mistake Spot Last Year
Sell of shares at $.019
And for a company that this posts states is failing, they seem to be doing very well to me over the past several years. I will let the numbers speak for RXMD, not baseless opinions. Stock price going from $.005 to now over $.06 and as high as $.2659 kinda coincides with that growth and achievements, not failures.
OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS
RXMD Revenues per location, Second to None
Penny Stock Exempt with low Share Structure
RXMD Compared to the Competition WOWSERS!!!
RXMD Retail Stores Commence Major Expansion Across Florida
RXMD 5 Star Humana Rating Earns Them Highest Payout
3 YEARS AUDITED F/S
Big Mistake Spot Last Year
Sell of shares at $.019
"To Give Anything Less Than Your Best, Is To Sacrifice the Gift." - Steve Prefontaine
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
